Research progress of small molecule targeted drugs for non-small cell lung cancer - Top-Institutions - MDSpire

Research progress of small molecule targeted drugs for non-small cell lung cancer

  • By

  • Tingxiang Qiu

  • Xin Huang

  • July 15, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    Vanderbilt University Ingram Cancer Center
    Vanderbilt University Ingram Cancer Center

    Nashville, Tennessee

    Key Differentiators

    • Oncology

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #5

    Columbia University Medical Center
    Columbia University Medical Center

    New York, New York

    Key Differentiators

    • Oncology

Original Source(s)

Research progress of small molecule targeted drugs for non-small cell lung cancer

  • by Tingxiang Qiu, Xin Huang

  • July 15, 2026

Related Content

Efficacy and safety of bupleurum-containing formulas combined with chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis

Evaluation of an interpretable deep-learning model for the automated plan review of intensity-modulated radiation therapy

Ancestry informative genetic variants associated with tobacco metabolic and detoxification capacity measured by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) among smokers